Indications |
Oral Oedema Adult: Initially, 40 mg daily in the morning, reduced to 20 mg daily according to response. Max: 80 mg daily. Renal impairment: Severe: Avoid. Hepatic impairment: Caution in use. Oral Hypertension Adult: 20 mg daily as a single dose in the morning. Renal impairment: Severe: Avoid. Hepatic impairment: Caution in use. Reconstitution: Ref: See PI. |
Contraindications |
Hypersensitivity to sulphonamide. Untreated Addison's disease. Severe renal failure; severe electrolyte deficiency; precomatose states associated with cirrhosis; lactation. |
Warnings / Precautions |
Pregnancy; elderly. Prostatic hypertrophy; renal or hepatic impairment; hypovolaemia; DM; hyperuricaemia; severe coronary or cerebral arteriosclerosis. |
Adverse Reactions |
GI disturbances; hypokalaemia; hyperuricaemia; nocturia, dizziness; impaired glucose metabolism. |
Overdose Reactions |
Symptoms: Hypotension, electrolyte and metabolic disturbances. Management: Reduce further absorption by gastric lavage or induced emesis. Treatment is supportive with BP maintenance and correction of electrolyte imbalances. |
Drug Interactions |
Antihypertensives enhance BP-lowering effects of xipamide. Increased risk of hypokalaemia with amphotericin B, carbenoxolone. Potentially Fatal: Propensity to cause hypokalaemia can increase risk of digitalis toxicity. See Below for More xipamide Drug Interactions |
Mechanism of Actions |
Xipamide is structurally related to indapamide and exerts its diuretic effect at the distal section of the nephron. Onset: 1-2 hr Duration: 12 hr Absorption: Rapid and well absorbed from GI tract. Peak plasma concentration: 1-2 hr. Distribution: Protein binding: 99%. Excretion: Excreted in urine as unchanged and glucuronide metabolite. Plasma half life: 5-8 hr. |
ATC Classification |
C03BA10 - xipamide ; Belongs to the class of low-ceiling sulfonamide diuretics. |
Available As |
|
Xipamide
Post Review about Xipamide Click here to cancel reply.
Xipamide Containing Brands
Xipamide is used in following diseases
Drug - Drug Interactions of Xipamide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.